OPHTHALMIC PRACTICE
Year : 2006 | Volume
: 54 | Issue : 2 | Page : 133--137
Intravitreal injection of triamcinolone acetonide for diabetic macular edema: Principles and practice
Vasumathy Vedantham, Ramasamy Kim Retina - Vitreous Service, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Madurai, Tamilnadu, India
Correspondence Address:
Vasumathy Vedantham Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, 1, Anna Nagar, Madurai - 625 020, Tamilnadu India
Diabetic retinopathy is fast emerging as a leading cause of newly diagnosed legal blindness amongst the working population. Macular edema, as it is commoner, accounts for more vision impairment than neovascular proliferation in diabetic patients. Laser photocoagulation, which is the standard treatment of macular edema, is associated with significant complications and an improvement in visual acuity is unsatisfactory. Intravitreal injection of corticosteroids (especially triamcinolone acetonide) is an emerging treatment modality in the management of diabetic macular edema. This article presents an overview of the principles, technique and complications associated with this procedure.
How to cite this article:
Vedantham V, Kim R. Intravitreal injection of triamcinolone acetonide for diabetic macular edema: Principles and practice.Indian J Ophthalmol 2006;54:133-137
|
How to cite this URL:
Vedantham V, Kim R. Intravitreal injection of triamcinolone acetonide for diabetic macular edema: Principles and practice. Indian J Ophthalmol [serial online] 2006 [cited 2024 Mar 29 ];54:133-137
Available from: https://journals.lww.com/ijo/pages/default.aspx/article.asp?issn=0301-4738;year=2006;volume=54;issue=2;spage=133;epage=137;aulast=Vedantham;type=0 |
|